 Braxia Scientific Corp. CSE:BRAX, OTC:BRAXF said it has successfully launched KetaMD in the US state of Florida, adding new patients and completing initial ketamine treatments. Eligible patients, as determined by one of KetaMDs licensed Florida healthcare practitioners, received medically supervised treatments, guided virtually by registered nurses with mental health expertise, while in the comfort of their homes, according to Braxia. 